Cargando…
Design of potent and highly selective inhibitors for human β-secretase 2 (memapsin 1), a target for type 2 diabetes
Design, synthesis and evaluation of very potent and selective β-secretase 2 (memapsin 1, BACE 2) inhibitors are described. The inhibitors were designed specifically to interact with the S2′-site of β-secretase 2 to provide >170 000-fold selectivity over β-secretase (BACE 1) and >15 000-fold se...
Autores principales: | Ghosh, Arun K., Reddy, Bhavanam Sekhara, Yen, Yu-Chen, Cárdenas, Emilio L., Rao, Kalapala Venkateswara, Downs, Deborah, Huang, Xiangping, Tang, Jordan, Mesecar, Andrew D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916918/ https://www.ncbi.nlm.nih.gov/pubmed/27347366 http://dx.doi.org/10.1039/c5sc03718b |
Ejemplares similares
-
Treating transgenic Alzheimer mice with a β-secretase inhibitor, what have we learned?
por: Tang, Jordan, et al.
Publicado: (2011) -
GRL-09510, a Unique P2-Crown-Tetrahydrofuranylurethane -Containing HIV-1 Protease Inhibitor, Maintains Its Favorable Antiviral Activity against Highly-Drug-Resistant HIV-1 Variants in vitro
por: Amano, Masayuki, et al.
Publicado: (2017) -
Pharmacological and Toxicological Properties of the Potent Oral γ-Secretase Modulator BPN-15606
por: Wagner, Steven L., et al.
Publicado: (2017) -
Cholestenoic acid, an endogenous cholesterol metabolite, is a potent γ-secretase modulator
por: Jung, Joo In, et al.
Publicado: (2015) -
Preclinical validation of a potent γ-secretase modulator for Alzheimer’s disease prevention
por: Rynearson, Kevin D., et al.
Publicado: (2021)